nodes	percent_of_prediction	percent_of_DWPC	metapath
Nevirapine—CYP3A5—Temsirolimus—kidney cancer	0.0811	0.118	CbGbCtD
Nevirapine—CYP2D6—Temsirolimus—kidney cancer	0.0498	0.0721	CbGbCtD
Nevirapine—CYP3A4—Everolimus—kidney cancer	0.0468	0.0679	CbGbCtD
Nevirapine—CYP1A2—Pazopanib—kidney cancer	0.0317	0.046	CbGbCtD
Nevirapine—CYP3A4—Temsirolimus—kidney cancer	0.0316	0.0459	CbGbCtD
Nevirapine—CYP2B6—Sorafenib—kidney cancer	0.0314	0.0455	CbGbCtD
Nevirapine—CYP3A5—Erlotinib—kidney cancer	0.0304	0.0441	CbGbCtD
Nevirapine—CYP2C9—Capecitabine—kidney cancer	0.0298	0.0432	CbGbCtD
Nevirapine—CYP3A5—Paclitaxel—kidney cancer	0.0278	0.0403	CbGbCtD
Nevirapine—CYP2D6—Pazopanib—kidney cancer	0.0261	0.0379	CbGbCtD
Nevirapine—CYP3A5—Sorafenib—kidney cancer	0.0247	0.0358	CbGbCtD
Nevirapine—CYP3A5—Vincristine—kidney cancer	0.024	0.0348	CbGbCtD
Nevirapine—CYP1A2—Erlotinib—kidney cancer	0.0226	0.0328	CbGbCtD
Nevirapine—CYP3A5—Sunitinib—kidney cancer	0.02	0.029	CbGbCtD
Nevirapine—CYP2B6—Doxorubicin—kidney cancer	0.019	0.0276	CbGbCtD
Nevirapine—CYP2C9—Paclitaxel—kidney cancer	0.0187	0.0271	CbGbCtD
Nevirapine—CYP2D6—Erlotinib—kidney cancer	0.0187	0.027	CbGbCtD
Nevirapine—CYP1A2—Sorafenib—kidney cancer	0.0184	0.0267	CbGbCtD
Nevirapine—CYP3A4—Pazopanib—kidney cancer	0.0166	0.0241	CbGbCtD
Nevirapine—CYP2C9—Sorafenib—kidney cancer	0.0166	0.024	CbGbCtD
Nevirapine—CYP2D6—Sorafenib—kidney cancer	0.0152	0.022	CbGbCtD
Nevirapine—CYP2D6—Vinblastine—kidney cancer	0.015	0.0217	CbGbCtD
Nevirapine—CYP3A4—Erlotinib—kidney cancer	0.0119	0.0172	CbGbCtD
Nevirapine—CYP3A4—Paclitaxel—kidney cancer	0.0109	0.0157	CbGbCtD
Nevirapine—CYP3A4—Sorafenib—kidney cancer	0.00964	0.014	CbGbCtD
Nevirapine—CYP3A4—Vinblastine—kidney cancer	0.00952	0.0138	CbGbCtD
Nevirapine—CYP3A4—Vincristine—kidney cancer	0.00936	0.0136	CbGbCtD
Nevirapine—CYP2D6—Doxorubicin—kidney cancer	0.0092	0.0133	CbGbCtD
Nevirapine—CYP3A4—Sunitinib—kidney cancer	0.00781	0.0113	CbGbCtD
Nevirapine—CYP3A4—Doxorubicin—kidney cancer	0.00585	0.00848	CbGbCtD
Nevirapine—CYP1A2—urine—kidney cancer	0.00152	0.161	CbGeAlD
Nevirapine—CYP2C9—urine—kidney cancer	0.00144	0.153	CbGeAlD
Nevirapine—CYP3A4—urine—kidney cancer	0.0011	0.117	CbGeAlD
Nevirapine—CYP2D6—urine—kidney cancer	0.00108	0.115	CbGeAlD
Nevirapine—CYP3A5—nephron tubule—kidney cancer	0.000394	0.0419	CbGeAlD
Nevirapine—CYP2B6—nephron tubule—kidney cancer	0.000391	0.0416	CbGeAlD
Nevirapine—CYP1A2—renal system—kidney cancer	0.000371	0.0395	CbGeAlD
Nevirapine—CYP3A5—renal system—kidney cancer	0.000358	0.0381	CbGeAlD
Nevirapine—CYP2B6—renal system—kidney cancer	0.000356	0.0379	CbGeAlD
Nevirapine—CYP3A5—kidney—kidney cancer	0.000346	0.0368	CbGeAlD
Nevirapine—CYP2B6—kidney—kidney cancer	0.000344	0.0366	CbGeAlD
Nevirapine—CYP3A5—cortex of kidney—kidney cancer	0.000337	0.0359	CbGeAlD
Nevirapine—CYP2B6—gonad—kidney cancer	0.000319	0.0339	CbGeAlD
Nevirapine—CYP3A4—renal system—kidney cancer	0.000269	0.0286	CbGeAlD
Nevirapine—CYP2D6—renal system—kidney cancer	0.000264	0.0281	CbGeAlD
Nevirapine—CYP3A4—kidney—kidney cancer	0.00026	0.0276	CbGeAlD
Nevirapine—CYP2D6—kidney—kidney cancer	0.000256	0.0272	CbGeAlD
Nevirapine—Asthenia—Vinblastine—kidney cancer	0.000212	0.000803	CcSEcCtD
Nevirapine—Fatigue—Sunitinib—kidney cancer	0.000212	0.000803	CcSEcCtD
Nevirapine—Asthenia—Everolimus—kidney cancer	0.000211	0.0008	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.000211	0.000798	CcSEcCtD
Nevirapine—Pain—Sunitinib—kidney cancer	0.00021	0.000797	CcSEcCtD
Nevirapine—Immune system disorder—Paclitaxel—kidney cancer	0.00021	0.000796	CcSEcCtD
Nevirapine—Gastrointestinal pain—Sorafenib—kidney cancer	0.000209	0.000792	CcSEcCtD
Nevirapine—Renal failure—Capecitabine—kidney cancer	0.000209	0.000792	CcSEcCtD
Nevirapine—Lymphadenopathy—Doxorubicin—kidney cancer	0.000208	0.000789	CcSEcCtD
Nevirapine—Neuropathy peripheral—Capecitabine—kidney cancer	0.000208	0.000789	CcSEcCtD
Nevirapine—Pruritus—Everolimus—kidney cancer	0.000208	0.000789	CcSEcCtD
Nevirapine—Anaphylactic shock—Vincristine—kidney cancer	0.000208	0.000788	CcSEcCtD
Nevirapine—Oedema—Vincristine—kidney cancer	0.000208	0.000788	CcSEcCtD
Nevirapine—Jaundice—Capecitabine—kidney cancer	0.000207	0.000785	CcSEcCtD
Nevirapine—Conjunctivitis—Capecitabine—kidney cancer	0.000206	0.000783	CcSEcCtD
Nevirapine—Arthralgia—Gemcitabine—kidney cancer	0.000206	0.00078	CcSEcCtD
Nevirapine—Myalgia—Gemcitabine—kidney cancer	0.000206	0.00078	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000204	0.000774	CcSEcCtD
Nevirapine—Nervous system disorder—Vincristine—kidney cancer	0.000204	0.000773	CcSEcCtD
Nevirapine—Asthenia—Erlotinib—kidney cancer	0.000204	0.000772	CcSEcCtD
Nevirapine—Thrombocytopenia—Vincristine—kidney cancer	0.000203	0.000771	CcSEcCtD
Nevirapine—Discomfort—Gemcitabine—kidney cancer	0.000203	0.00077	CcSEcCtD
Nevirapine—Urticaria—Sorafenib—kidney cancer	0.000203	0.000769	CcSEcCtD
Nevirapine—Erythema—Paclitaxel—kidney cancer	0.000202	0.000767	CcSEcCtD
Nevirapine—Decreased appetite—Dactinomycin—kidney cancer	0.000202	0.000767	CcSEcCtD
Nevirapine—Diarrhoea—Vinblastine—kidney cancer	0.000202	0.000766	CcSEcCtD
Nevirapine—Body temperature increased—Sorafenib—kidney cancer	0.000202	0.000765	CcSEcCtD
Nevirapine—Abdominal pain—Sorafenib—kidney cancer	0.000202	0.000765	CcSEcCtD
Nevirapine—Diarrhoea—Everolimus—kidney cancer	0.000201	0.000763	CcSEcCtD
Nevirapine—Gastrointestinal pain—Sunitinib—kidney cancer	0.000201	0.000762	CcSEcCtD
Nevirapine—Hepatobiliary disease—Capecitabine—kidney cancer	0.000201	0.000762	CcSEcCtD
Nevirapine—Pruritus—Erlotinib—kidney cancer	0.000201	0.000761	CcSEcCtD
Nevirapine—Fatigue—Dactinomycin—kidney cancer	0.0002	0.00076	CcSEcCtD
Nevirapine—Pain—Dactinomycin—kidney cancer	0.000199	0.000754	CcSEcCtD
Nevirapine—Agranulocytosis—Capecitabine—kidney cancer	0.000198	0.000751	CcSEcCtD
Nevirapine—Anorexia—Vincristine—kidney cancer	0.000198	0.000751	CcSEcCtD
Nevirapine—Hepatic failure—Doxorubicin—kidney cancer	0.000198	0.00075	CcSEcCtD
Nevirapine—Oedema—Gemcitabine—kidney cancer	0.000197	0.000747	CcSEcCtD
Nevirapine—Anaphylactic shock—Gemcitabine—kidney cancer	0.000197	0.000747	CcSEcCtD
Nevirapine—Abdominal pain—Sunitinib—kidney cancer	0.000194	0.000736	CcSEcCtD
Nevirapine—Body temperature increased—Sunitinib—kidney cancer	0.000194	0.000736	CcSEcCtD
Nevirapine—Diarrhoea—Erlotinib—kidney cancer	0.000194	0.000736	CcSEcCtD
Nevirapine—Nervous system disorder—Gemcitabine—kidney cancer	0.000193	0.000733	CcSEcCtD
Nevirapine—Thrombocytopenia—Gemcitabine—kidney cancer	0.000193	0.000732	CcSEcCtD
Nevirapine—Feeling abnormal—Dactinomycin—kidney cancer	0.000192	0.000727	CcSEcCtD
Nevirapine—Skin disorder—Gemcitabine—kidney cancer	0.000191	0.000726	CcSEcCtD
Nevirapine—Hepatitis—Capecitabine—kidney cancer	0.000191	0.000723	CcSEcCtD
Nevirapine—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00019	0.000721	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000189	0.000718	CcSEcCtD
Nevirapine—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.000188	0.000714	CcSEcCtD
Nevirapine—Hypersensitivity—Sorafenib—kidney cancer	0.000188	0.000713	CcSEcCtD
Nevirapine—Anorexia—Gemcitabine—kidney cancer	0.000188	0.000713	CcSEcCtD
Nevirapine—Vomiting—Vinblastine—kidney cancer	0.000188	0.000712	CcSEcCtD
Nevirapine—Ill-defined disorder—Paclitaxel—kidney cancer	0.000188	0.000711	CcSEcCtD
Nevirapine—Connective tissue disorder—Capecitabine—kidney cancer	0.000187	0.00071	CcSEcCtD
Nevirapine—Vomiting—Everolimus—kidney cancer	0.000187	0.000709	CcSEcCtD
Nevirapine—Anaemia—Paclitaxel—kidney cancer	0.000187	0.000709	CcSEcCtD
Nevirapine—Paraesthesia—Vincristine—kidney cancer	0.000187	0.000708	CcSEcCtD
Nevirapine—Dermatitis bullous—Doxorubicin—kidney cancer	0.000186	0.000705	CcSEcCtD
Nevirapine—Rash—Everolimus—kidney cancer	0.000185	0.000703	CcSEcCtD
Nevirapine—Dermatitis—Everolimus—kidney cancer	0.000185	0.000703	CcSEcCtD
Nevirapine—Headache—Vinblastine—kidney cancer	0.000185	0.000701	CcSEcCtD
Nevirapine—Angioedema—Paclitaxel—kidney cancer	0.000185	0.000701	CcSEcCtD
Nevirapine—Headache—Everolimus—kidney cancer	0.000184	0.000699	CcSEcCtD
Nevirapine—Body temperature increased—Dactinomycin—kidney cancer	0.000184	0.000697	CcSEcCtD
Nevirapine—Abdominal pain—Dactinomycin—kidney cancer	0.000184	0.000697	CcSEcCtD
Nevirapine—Asthenia—Sorafenib—kidney cancer	0.000183	0.000695	CcSEcCtD
Nevirapine—Malaise—Paclitaxel—kidney cancer	0.000182	0.000692	CcSEcCtD
Nevirapine—Hypersensitivity—Sunitinib—kidney cancer	0.000181	0.000686	CcSEcCtD
Nevirapine—Decreased appetite—Vincristine—kidney cancer	0.000181	0.000685	CcSEcCtD
Nevirapine—Pruritus—Sorafenib—kidney cancer	0.000181	0.000685	CcSEcCtD
Nevirapine—Vomiting—Erlotinib—kidney cancer	0.00018	0.000684	CcSEcCtD
Nevirapine—Erythema multiforme—Capecitabine—kidney cancer	0.00018	0.000684	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.00018	0.000681	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Vincristine—kidney cancer	0.000179	0.00068	CcSEcCtD
Nevirapine—Fatigue—Vincristine—kidney cancer	0.000179	0.000679	CcSEcCtD
Nevirapine—Rash—Erlotinib—kidney cancer	0.000179	0.000679	CcSEcCtD
Nevirapine—Dermatitis—Erlotinib—kidney cancer	0.000179	0.000678	CcSEcCtD
Nevirapine—Headache—Erlotinib—kidney cancer	0.000178	0.000674	CcSEcCtD
Nevirapine—Pain—Vincristine—kidney cancer	0.000178	0.000674	CcSEcCtD
Nevirapine—Paraesthesia—Gemcitabine—kidney cancer	0.000177	0.000671	CcSEcCtD
Nevirapine—Asthenia—Sunitinib—kidney cancer	0.000176	0.000668	CcSEcCtD
Nevirapine—Nausea—Vinblastine—kidney cancer	0.000175	0.000665	CcSEcCtD
Nevirapine—Somnolence—Gemcitabine—kidney cancer	0.000175	0.000665	CcSEcCtD
Nevirapine—Nausea—Everolimus—kidney cancer	0.000175	0.000662	CcSEcCtD
Nevirapine—Diarrhoea—Sorafenib—kidney cancer	0.000175	0.000662	CcSEcCtD
Nevirapine—Pruritus—Sunitinib—kidney cancer	0.000174	0.000659	CcSEcCtD
Nevirapine—Immune system disorder—Capecitabine—kidney cancer	0.000172	0.000653	CcSEcCtD
Nevirapine—Arthralgia—Paclitaxel—kidney cancer	0.000172	0.000653	CcSEcCtD
Nevirapine—Myalgia—Paclitaxel—kidney cancer	0.000172	0.000653	CcSEcCtD
Nevirapine—Face oedema—Doxorubicin—kidney cancer	0.000171	0.00065	CcSEcCtD
Nevirapine—Decreased appetite—Gemcitabine—kidney cancer	0.000171	0.00065	CcSEcCtD
Nevirapine—Hypersensitivity—Dactinomycin—kidney cancer	0.000171	0.00065	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000171	0.000648	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.00017	0.000645	CcSEcCtD
Nevirapine—Discomfort—Paclitaxel—kidney cancer	0.00017	0.000645	CcSEcCtD
Nevirapine—Fatigue—Gemcitabine—kidney cancer	0.00017	0.000644	CcSEcCtD
Nevirapine—Gastrointestinal pain—Vincristine—kidney cancer	0.00017	0.000644	CcSEcCtD
Nevirapine—Pain—Gemcitabine—kidney cancer	0.000169	0.000639	CcSEcCtD
Nevirapine—Nausea—Erlotinib—kidney cancer	0.000169	0.000639	CcSEcCtD
Nevirapine—Diarrhoea—Sunitinib—kidney cancer	0.000168	0.000637	CcSEcCtD
Nevirapine—Asthenia—Dactinomycin—kidney cancer	0.000167	0.000633	CcSEcCtD
Nevirapine—Erythema—Capecitabine—kidney cancer	0.000166	0.000629	CcSEcCtD
Nevirapine—Oedema—Paclitaxel—kidney cancer	0.000165	0.000626	CcSEcCtD
Nevirapine—Anaphylactic shock—Paclitaxel—kidney cancer	0.000165	0.000626	CcSEcCtD
Nevirapine—Body temperature increased—Vincristine—kidney cancer	0.000164	0.000623	CcSEcCtD
Nevirapine—Abdominal pain—Vincristine—kidney cancer	0.000164	0.000623	CcSEcCtD
Nevirapine—Liver function test abnormal—Doxorubicin—kidney cancer	0.000164	0.000622	CcSEcCtD
Nevirapine—Feeling abnormal—Gemcitabine—kidney cancer	0.000162	0.000616	CcSEcCtD
Nevirapine—Vomiting—Sorafenib—kidney cancer	0.000162	0.000616	CcSEcCtD
Nevirapine—Nervous system disorder—Paclitaxel—kidney cancer	0.000162	0.000614	CcSEcCtD
Nevirapine—Thrombocytopenia—Paclitaxel—kidney cancer	0.000162	0.000613	CcSEcCtD
Nevirapine—Rash—Sorafenib—kidney cancer	0.000161	0.00061	CcSEcCtD
Nevirapine—Dermatitis—Sorafenib—kidney cancer	0.000161	0.00061	CcSEcCtD
Nevirapine—Skin disorder—Paclitaxel—kidney cancer	0.00016	0.000608	CcSEcCtD
Nevirapine—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.00016	0.000607	CcSEcCtD
Nevirapine—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.00016	0.000607	CcSEcCtD
Nevirapine—Headache—Sorafenib—kidney cancer	0.00016	0.000607	CcSEcCtD
Nevirapine—Diarrhoea—Dactinomycin—kidney cancer	0.000159	0.000603	CcSEcCtD
Nevirapine—Anorexia—Paclitaxel—kidney cancer	0.000157	0.000597	CcSEcCtD
Nevirapine—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000157	0.000594	CcSEcCtD
Nevirapine—Vomiting—Sunitinib—kidney cancer	0.000156	0.000592	CcSEcCtD
Nevirapine—Body temperature increased—Gemcitabine—kidney cancer	0.000156	0.000591	CcSEcCtD
Nevirapine—Rash—Sunitinib—kidney cancer	0.000155	0.000587	CcSEcCtD
Nevirapine—Dermatitis—Sunitinib—kidney cancer	0.000155	0.000587	CcSEcCtD
Nevirapine—Ill-defined disorder—Capecitabine—kidney cancer	0.000154	0.000584	CcSEcCtD
Nevirapine—Headache—Sunitinib—kidney cancer	0.000154	0.000584	CcSEcCtD
Nevirapine—Anaemia—Capecitabine—kidney cancer	0.000153	0.000582	CcSEcCtD
Nevirapine—Hypersensitivity—Vincristine—kidney cancer	0.000153	0.000581	CcSEcCtD
Nevirapine—Eosinophilia—Doxorubicin—kidney cancer	0.000152	0.000576	CcSEcCtD
Nevirapine—Nausea—Sorafenib—kidney cancer	0.000152	0.000575	CcSEcCtD
Nevirapine—Pancreatitis—Doxorubicin—kidney cancer	0.00015	0.000571	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.00015	0.00057	CcSEcCtD
Nevirapine—Malaise—Capecitabine—kidney cancer	0.00015	0.000567	CcSEcCtD
Nevirapine—Asthenia—Vincristine—kidney cancer	0.000149	0.000565	CcSEcCtD
Nevirapine—Paraesthesia—Paclitaxel—kidney cancer	0.000148	0.000562	CcSEcCtD
Nevirapine—Vomiting—Dactinomycin—kidney cancer	0.000148	0.000561	CcSEcCtD
Nevirapine—Somnolence—Paclitaxel—kidney cancer	0.000147	0.000556	CcSEcCtD
Nevirapine—Rash—Dactinomycin—kidney cancer	0.000147	0.000556	CcSEcCtD
Nevirapine—Nausea—Sunitinib—kidney cancer	0.000146	0.000553	CcSEcCtD
Nevirapine—Neutropenia—Doxorubicin—kidney cancer	0.000144	0.000544	CcSEcCtD
Nevirapine—Decreased appetite—Paclitaxel—kidney cancer	0.000143	0.000544	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000142	0.00054	CcSEcCtD
Nevirapine—Fatigue—Paclitaxel—kidney cancer	0.000142	0.00054	CcSEcCtD
Nevirapine—Diarrhoea—Vincristine—kidney cancer	0.000142	0.000539	CcSEcCtD
Nevirapine—Asthenia—Gemcitabine—kidney cancer	0.000141	0.000536	CcSEcCtD
Nevirapine—Arthralgia—Capecitabine—kidney cancer	0.000141	0.000536	CcSEcCtD
Nevirapine—Myalgia—Capecitabine—kidney cancer	0.000141	0.000536	CcSEcCtD
Nevirapine—Pain—Paclitaxel—kidney cancer	0.000141	0.000535	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.00014	0.000532	CcSEcCtD
Nevirapine—Discomfort—Capecitabine—kidney cancer	0.00014	0.000529	CcSEcCtD
Nevirapine—Pruritus—Gemcitabine—kidney cancer	0.000139	0.000529	CcSEcCtD
Nevirapine—Hyperglycaemia—Doxorubicin—kidney cancer	0.000138	0.000525	CcSEcCtD
Nevirapine—Nausea—Dactinomycin—kidney cancer	0.000138	0.000524	CcSEcCtD
Nevirapine—Feeling abnormal—Paclitaxel—kidney cancer	0.000136	0.000516	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000136	0.000515	CcSEcCtD
Nevirapine—Oedema—Capecitabine—kidney cancer	0.000135	0.000514	CcSEcCtD
Nevirapine—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000135	0.000512	CcSEcCtD
Nevirapine—Diarrhoea—Gemcitabine—kidney cancer	0.000135	0.000511	CcSEcCtD
Nevirapine—Renal failure—Doxorubicin—kidney cancer	0.000135	0.00051	CcSEcCtD
Nevirapine—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000134	0.000509	CcSEcCtD
Nevirapine—Jaundice—Doxorubicin—kidney cancer	0.000133	0.000506	CcSEcCtD
Nevirapine—Conjunctivitis—Doxorubicin—kidney cancer	0.000133	0.000505	CcSEcCtD
Nevirapine—Nervous system disorder—Capecitabine—kidney cancer	0.000133	0.000504	CcSEcCtD
Nevirapine—Thrombocytopenia—Capecitabine—kidney cancer	0.000133	0.000503	CcSEcCtD
Nevirapine—Vomiting—Vincristine—kidney cancer	0.000132	0.000501	CcSEcCtD
Nevirapine—Skin disorder—Capecitabine—kidney cancer	0.000132	0.000499	CcSEcCtD
Nevirapine—Urticaria—Paclitaxel—kidney cancer	0.000131	0.000497	CcSEcCtD
Nevirapine—Rash—Vincristine—kidney cancer	0.000131	0.000497	CcSEcCtD
Nevirapine—Dermatitis—Vincristine—kidney cancer	0.000131	0.000496	CcSEcCtD
Nevirapine—Abdominal pain—Paclitaxel—kidney cancer	0.00013	0.000495	CcSEcCtD
Nevirapine—Body temperature increased—Paclitaxel—kidney cancer	0.00013	0.000495	CcSEcCtD
Nevirapine—Headache—Vincristine—kidney cancer	0.00013	0.000494	CcSEcCtD
Nevirapine—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000129	0.000491	CcSEcCtD
Nevirapine—Anorexia—Capecitabine—kidney cancer	0.000129	0.00049	CcSEcCtD
Nevirapine—Agranulocytosis—Doxorubicin—kidney cancer	0.000128	0.000484	CcSEcCtD
Nevirapine—Vomiting—Gemcitabine—kidney cancer	0.000125	0.000475	CcSEcCtD
Nevirapine—Rash—Gemcitabine—kidney cancer	0.000124	0.000471	CcSEcCtD
Nevirapine—Dermatitis—Gemcitabine—kidney cancer	0.000124	0.000471	CcSEcCtD
Nevirapine—Headache—Gemcitabine—kidney cancer	0.000123	0.000468	CcSEcCtD
Nevirapine—Nausea—Vincristine—kidney cancer	0.000123	0.000468	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000123	0.000468	CcSEcCtD
Nevirapine—Hepatitis—Doxorubicin—kidney cancer	0.000123	0.000466	CcSEcCtD
Nevirapine—Paraesthesia—Capecitabine—kidney cancer	0.000122	0.000461	CcSEcCtD
Nevirapine—Hypersensitivity—Paclitaxel—kidney cancer	0.000122	0.000461	CcSEcCtD
Nevirapine—Connective tissue disorder—Doxorubicin—kidney cancer	0.000121	0.000458	CcSEcCtD
Nevirapine—Asthenia—Paclitaxel—kidney cancer	0.000118	0.000449	CcSEcCtD
Nevirapine—Decreased appetite—Capecitabine—kidney cancer	0.000118	0.000446	CcSEcCtD
Nevirapine—Nausea—Gemcitabine—kidney cancer	0.000117	0.000444	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000117	0.000443	CcSEcCtD
Nevirapine—Fatigue—Capecitabine—kidney cancer	0.000117	0.000443	CcSEcCtD
Nevirapine—Pruritus—Paclitaxel—kidney cancer	0.000117	0.000443	CcSEcCtD
Nevirapine—Erythema multiforme—Doxorubicin—kidney cancer	0.000116	0.000441	CcSEcCtD
Nevirapine—Pain—Capecitabine—kidney cancer	0.000116	0.000439	CcSEcCtD
Nevirapine—Diarrhoea—Paclitaxel—kidney cancer	0.000113	0.000428	CcSEcCtD
Nevirapine—Feeling abnormal—Capecitabine—kidney cancer	0.000112	0.000423	CcSEcCtD
Nevirapine—Immune system disorder—Doxorubicin—kidney cancer	0.000111	0.000421	CcSEcCtD
Nevirapine—Gastrointestinal pain—Capecitabine—kidney cancer	0.000111	0.00042	CcSEcCtD
Nevirapine—Urticaria—Capecitabine—kidney cancer	0.000108	0.000408	CcSEcCtD
Nevirapine—Body temperature increased—Capecitabine—kidney cancer	0.000107	0.000406	CcSEcCtD
Nevirapine—Abdominal pain—Capecitabine—kidney cancer	0.000107	0.000406	CcSEcCtD
Nevirapine—Erythema—Doxorubicin—kidney cancer	0.000107	0.000406	CcSEcCtD
Nevirapine—Vomiting—Paclitaxel—kidney cancer	0.000105	0.000398	CcSEcCtD
Nevirapine—Rash—Paclitaxel—kidney cancer	0.000104	0.000395	CcSEcCtD
Nevirapine—Dermatitis—Paclitaxel—kidney cancer	0.000104	0.000394	CcSEcCtD
Nevirapine—Headache—Paclitaxel—kidney cancer	0.000103	0.000392	CcSEcCtD
Nevirapine—Hypersensitivity—Capecitabine—kidney cancer	9.98e-05	0.000378	CcSEcCtD
Nevirapine—Ill-defined disorder—Doxorubicin—kidney cancer	9.92e-05	0.000376	CcSEcCtD
Nevirapine—Anaemia—Doxorubicin—kidney cancer	9.89e-05	0.000375	CcSEcCtD
Nevirapine—Nausea—Paclitaxel—kidney cancer	9.8e-05	0.000372	CcSEcCtD
Nevirapine—Asthenia—Capecitabine—kidney cancer	9.72e-05	0.000368	CcSEcCtD
Nevirapine—Malaise—Doxorubicin—kidney cancer	9.65e-05	0.000366	CcSEcCtD
Nevirapine—Pruritus—Capecitabine—kidney cancer	9.58e-05	0.000363	CcSEcCtD
Nevirapine—Diarrhoea—Capecitabine—kidney cancer	9.27e-05	0.000351	CcSEcCtD
Nevirapine—Arthralgia—Doxorubicin—kidney cancer	9.11e-05	0.000345	CcSEcCtD
Nevirapine—Myalgia—Doxorubicin—kidney cancer	9.11e-05	0.000345	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	9.04e-05	0.000343	CcSEcCtD
Nevirapine—Discomfort—Doxorubicin—kidney cancer	9e-05	0.000341	CcSEcCtD
Nevirapine—Oedema—Doxorubicin—kidney cancer	8.73e-05	0.000331	CcSEcCtD
Nevirapine—Anaphylactic shock—Doxorubicin—kidney cancer	8.73e-05	0.000331	CcSEcCtD
Nevirapine—Vomiting—Capecitabine—kidney cancer	8.61e-05	0.000327	CcSEcCtD
Nevirapine—Nervous system disorder—Doxorubicin—kidney cancer	8.56e-05	0.000325	CcSEcCtD
Nevirapine—Thrombocytopenia—Doxorubicin—kidney cancer	8.55e-05	0.000324	CcSEcCtD
Nevirapine—Rash—Capecitabine—kidney cancer	8.54e-05	0.000324	CcSEcCtD
Nevirapine—Dermatitis—Capecitabine—kidney cancer	8.53e-05	0.000324	CcSEcCtD
Nevirapine—Headache—Capecitabine—kidney cancer	8.48e-05	0.000322	CcSEcCtD
Nevirapine—Skin disorder—Doxorubicin—kidney cancer	8.48e-05	0.000322	CcSEcCtD
Nevirapine—Anorexia—Doxorubicin—kidney cancer	8.32e-05	0.000316	CcSEcCtD
Nevirapine—Nausea—Capecitabine—kidney cancer	8.04e-05	0.000305	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	7.95e-05	0.000302	CcSEcCtD
Nevirapine—Paraesthesia—Doxorubicin—kidney cancer	7.84e-05	0.000297	CcSEcCtD
Nevirapine—Somnolence—Doxorubicin—kidney cancer	7.76e-05	0.000294	CcSEcCtD
Nevirapine—Decreased appetite—Doxorubicin—kidney cancer	7.59e-05	0.000288	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Doxorubicin—kidney cancer	7.54e-05	0.000286	CcSEcCtD
Nevirapine—Fatigue—Doxorubicin—kidney cancer	7.53e-05	0.000285	CcSEcCtD
Nevirapine—Pain—Doxorubicin—kidney cancer	7.46e-05	0.000283	CcSEcCtD
Nevirapine—Feeling abnormal—Doxorubicin—kidney cancer	7.19e-05	0.000273	CcSEcCtD
Nevirapine—Gastrointestinal pain—Doxorubicin—kidney cancer	7.14e-05	0.000271	CcSEcCtD
Nevirapine—Urticaria—Doxorubicin—kidney cancer	6.93e-05	0.000263	CcSEcCtD
Nevirapine—Body temperature increased—Doxorubicin—kidney cancer	6.9e-05	0.000262	CcSEcCtD
Nevirapine—Abdominal pain—Doxorubicin—kidney cancer	6.9e-05	0.000262	CcSEcCtD
Nevirapine—Hypersensitivity—Doxorubicin—kidney cancer	6.43e-05	0.000244	CcSEcCtD
Nevirapine—Asthenia—Doxorubicin—kidney cancer	6.26e-05	0.000238	CcSEcCtD
Nevirapine—Pruritus—Doxorubicin—kidney cancer	6.18e-05	0.000234	CcSEcCtD
Nevirapine—Diarrhoea—Doxorubicin—kidney cancer	5.97e-05	0.000227	CcSEcCtD
Nevirapine—Vomiting—Doxorubicin—kidney cancer	5.55e-05	0.00021	CcSEcCtD
Nevirapine—Rash—Doxorubicin—kidney cancer	5.5e-05	0.000209	CcSEcCtD
Nevirapine—Dermatitis—Doxorubicin—kidney cancer	5.5e-05	0.000209	CcSEcCtD
Nevirapine—Headache—Doxorubicin—kidney cancer	5.47e-05	0.000207	CcSEcCtD
Nevirapine—Nausea—Doxorubicin—kidney cancer	5.18e-05	0.000197	CcSEcCtD
Nevirapine—CYP2C9—Metabolism—ACY1—kidney cancer	2.99e-05	0.000811	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—ALDH1A1—kidney cancer	2.94e-05	0.000799	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PPAT—kidney cancer	2.94e-05	0.000797	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GLIPR1—kidney cancer	2.94e-05	0.000797	CbGpPWpGaD
Nevirapine—CYP1A2—Biological oxidations—CYP1A1—kidney cancer	2.9e-05	0.000788	CbGpPWpGaD
Nevirapine—CYP1A2—Metapathway biotransformation—CYP1A1—kidney cancer	2.86e-05	0.000777	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—SLC5A3—kidney cancer	2.82e-05	0.000766	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PGK1—kidney cancer	2.82e-05	0.000766	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—APRT—kidney cancer	2.79e-05	0.000758	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—FH—kidney cancer	2.79e-05	0.000758	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—LDHB—kidney cancer	2.77e-05	0.000751	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—APRT—kidney cancer	2.73e-05	0.000741	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—FH—kidney cancer	2.73e-05	0.000741	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GPC3—kidney cancer	2.63e-05	0.000713	CbGpPWpGaD
Nevirapine—CYP3A4—Biological oxidations—GSTP1—kidney cancer	2.57e-05	0.000698	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GPC3—kidney cancer	2.57e-05	0.000697	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PDHB—kidney cancer	2.56e-05	0.000696	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CA2—kidney cancer	2.56e-05	0.000694	CbGpPWpGaD
Nevirapine—CYP2D6—Biological oxidations—POMC—kidney cancer	2.55e-05	0.000693	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ACY1—kidney cancer	2.55e-05	0.000693	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.55e-05	0.000692	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PDHB—kidney cancer	2.54e-05	0.000689	CbGpPWpGaD
Nevirapine—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	2.54e-05	0.000688	CbGpPWpGaD
Nevirapine—CYP2C9—Biological oxidations—POMC—kidney cancer	2.53e-05	0.000687	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CA2—kidney cancer	2.5e-05	0.000678	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ALAD—kidney cancer	2.49e-05	0.000676	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ALAD—kidney cancer	2.43e-05	0.000661	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ST3GAL2—kidney cancer	2.43e-05	0.00066	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CCBL1—kidney cancer	2.41e-05	0.000654	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CA9—kidney cancer	2.4e-05	0.000652	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CCBL1—kidney cancer	2.39e-05	0.000648	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ST3GAL2—kidney cancer	2.38e-05	0.000645	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ALDH1A1—kidney cancer	2.38e-05	0.000645	CbGpPWpGaD
Nevirapine—CYP3A4—Biological oxidations—GSTM1—kidney cancer	2.36e-05	0.000641	CbGpPWpGaD
Nevirapine—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	2.33e-05	0.000633	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ALDH1A1—kidney cancer	2.32e-05	0.00063	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PGK1—kidney cancer	2.28e-05	0.000618	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—SLC5A3—kidney cancer	2.28e-05	0.000618	CbGpPWpGaD
Nevirapine—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	2.24e-05	0.000608	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—LDHB—kidney cancer	2.23e-05	0.000606	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PGK1—kidney cancer	2.23e-05	0.000604	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—SLC5A3—kidney cancer	2.23e-05	0.000604	CbGpPWpGaD
Nevirapine—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	2.21e-05	0.0006	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—LDHB—kidney cancer	2.18e-05	0.000593	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.18e-05	0.000591	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PDHB—kidney cancer	2.17e-05	0.000589	CbGpPWpGaD
Nevirapine—CYP1A2—Biological oxidations—POMC—kidney cancer	2.16e-05	0.000587	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.16e-05	0.000586	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GLIPR1—kidney cancer	2.09e-05	0.000567	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PPAT—kidney cancer	2.09e-05	0.000567	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PPAT—kidney cancer	2.07e-05	0.000562	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GLIPR1—kidney cancer	2.07e-05	0.000562	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.04e-05	0.000555	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CCBL1—kidney cancer	2.04e-05	0.000554	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CRABP1—kidney cancer	2.04e-05	0.000554	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.02e-05	0.000549	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ACY1—kidney cancer	1.97e-05	0.000535	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—APRT—kidney cancer	1.94e-05	0.000527	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—FH—kidney cancer	1.94e-05	0.000527	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CA9—kidney cancer	1.94e-05	0.000526	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—APRT—kidney cancer	1.93e-05	0.000523	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—FH—kidney cancer	1.93e-05	0.000523	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—ITPR2—kidney cancer	1.9e-05	0.000515	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CA9—kidney cancer	1.89e-05	0.000514	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.88e-05	0.000511	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.85e-05	0.000501	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GPC3—kidney cancer	1.83e-05	0.000496	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GPC3—kidney cancer	1.81e-05	0.000491	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CA2—kidney cancer	1.78e-05	0.000482	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PPAT—kidney cancer	1.77e-05	0.00048	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GLIPR1—kidney cancer	1.77e-05	0.00048	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CA2—kidney cancer	1.76e-05	0.000478	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.75e-05	0.000474	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ALAD—kidney cancer	1.73e-05	0.00047	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—ACHE—kidney cancer	1.73e-05	0.00047	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—GSTT1—kidney cancer	1.73e-05	0.00047	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.73e-05	0.000469	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ALAD—kidney cancer	1.72e-05	0.000466	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ST3GAL2—kidney cancer	1.69e-05	0.000459	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PDHB—kidney cancer	1.68e-05	0.000455	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.67e-05	0.000455	CbGpPWpGaD
Nevirapine—CYP3A4—Biological oxidations—POMC—kidney cancer	1.67e-05	0.000453	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ALDH1A1—kidney cancer	1.65e-05	0.000448	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CRABP1—kidney cancer	1.65e-05	0.000447	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—FH—kidney cancer	1.65e-05	0.000447	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—APRT—kidney cancer	1.65e-05	0.000447	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—SCARB1—kidney cancer	1.64e-05	0.000445	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.64e-05	0.000444	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PTGS1—kidney cancer	1.62e-05	0.00044	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CRABP1—kidney cancer	1.61e-05	0.000437	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.61e-05	0.000436	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PSMD7—kidney cancer	1.59e-05	0.000432	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PGK1—kidney cancer	1.58e-05	0.00043	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—SLC5A3—kidney cancer	1.58e-05	0.00043	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CCBL1—kidney cancer	1.58e-05	0.000428	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.57e-05	0.000426	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PGK1—kidney cancer	1.57e-05	0.000426	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—LDHB—kidney cancer	1.55e-05	0.000421	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GPC3—kidney cancer	1.55e-05	0.00042	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—LDHB—kidney cancer	1.54e-05	0.000418	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ITPR2—kidney cancer	1.53e-05	0.000416	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—BCHE—kidney cancer	1.51e-05	0.000409	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CA2—kidney cancer	1.5e-05	0.000408	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ITPR2—kidney cancer	1.5e-05	0.000406	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—SLC5A5—kidney cancer	1.49e-05	0.000404	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ALAD—kidney cancer	1.47e-05	0.000398	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—SLC2A1—kidney cancer	1.44e-05	0.00039	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ST3GAL2—kidney cancer	1.43e-05	0.000388	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ALDH1A1—kidney cancer	1.4e-05	0.00038	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ACHE—kidney cancer	1.4e-05	0.000379	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GSTT1—kidney cancer	1.4e-05	0.000379	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.37e-05	0.000371	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PPAT—kidney cancer	1.37e-05	0.000371	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GSTT1—kidney cancer	1.36e-05	0.00037	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ACHE—kidney cancer	1.36e-05	0.00037	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CA9—kidney cancer	1.35e-05	0.000365	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PGK1—kidney cancer	1.34e-05	0.000364	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—SLC5A3—kidney cancer	1.34e-05	0.000364	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CA9—kidney cancer	1.33e-05	0.000362	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—SCARB1—kidney cancer	1.32e-05	0.000359	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—LDHB—kidney cancer	1.32e-05	0.000357	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PTGS1—kidney cancer	1.31e-05	0.000355	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.3e-05	0.000354	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—SCARB1—kidney cancer	1.29e-05	0.000351	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PSMD7—kidney cancer	1.28e-05	0.000348	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PTGS1—kidney cancer	1.28e-05	0.000347	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—FH—kidney cancer	1.27e-05	0.000345	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—APRT—kidney cancer	1.27e-05	0.000345	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PSMD7—kidney cancer	1.25e-05	0.00034	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—BCHE—kidney cancer	1.22e-05	0.00033	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—SLC5A5—kidney cancer	1.2e-05	0.000326	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—GSTP1—kidney cancer	1.2e-05	0.000326	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GPC3—kidney cancer	1.19e-05	0.000324	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—BCHE—kidney cancer	1.19e-05	0.000323	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—SLC5A5—kidney cancer	1.17e-05	0.000319	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CA2—kidney cancer	1.16e-05	0.000315	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—SLC2A1—kidney cancer	1.16e-05	0.000315	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CRABP1—kidney cancer	1.14e-05	0.000311	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CA9—kidney cancer	1.14e-05	0.00031	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—ABCB1—kidney cancer	1.14e-05	0.000308	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CRABP1—kidney cancer	1.13e-05	0.000308	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—SLC2A1—kidney cancer	1.13e-05	0.000308	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ALAD—kidney cancer	1.13e-05	0.000307	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.11e-05	0.000303	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.1e-05	0.0003	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—GSTM1—kidney cancer	1.1e-05	0.000299	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.08e-05	0.000293	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ITPR2—kidney cancer	1.06e-05	0.000289	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ITPR2—kidney cancer	1.05e-05	0.000286	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CYP1A1—kidney cancer	1.04e-05	0.000284	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PGK1—kidney cancer	1.03e-05	0.000281	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.03e-05	0.000281	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—LDHB—kidney cancer	1.01e-05	0.000276	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.72e-06	0.000264	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GSTT1—kidney cancer	9.7e-06	0.000263	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ACHE—kidney cancer	9.7e-06	0.000263	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CRABP1—kidney cancer	9.7e-06	0.000263	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GSTP1—kidney cancer	9.68e-06	0.000263	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GSTT1—kidney cancer	9.62e-06	0.000261	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ACHE—kidney cancer	9.62e-06	0.000261	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GSTP1—kidney cancer	9.46e-06	0.000257	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—SCARB1—kidney cancer	9.18e-06	0.000249	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ABCB1—kidney cancer	9.16e-06	0.000249	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—SCARB1—kidney cancer	9.1e-06	0.000247	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PTGS1—kidney cancer	9.09e-06	0.000247	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ITPR2—kidney cancer	9.01e-06	0.000245	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PTGS1—kidney cancer	9.01e-06	0.000245	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ABCB1—kidney cancer	8.95e-06	0.000243	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PSMD7—kidney cancer	8.92e-06	0.000242	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GSTM1—kidney cancer	8.89e-06	0.000241	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PSMD7—kidney cancer	8.84e-06	0.00024	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CA9—kidney cancer	8.8e-06	0.000239	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GSTM1—kidney cancer	8.69e-06	0.000236	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—BCHE—kidney cancer	8.45e-06	0.000229	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CYP1A1—kidney cancer	8.43e-06	0.000229	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—BCHE—kidney cancer	8.38e-06	0.000227	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—SLC5A5—kidney cancer	8.35e-06	0.000227	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	8.31e-06	0.000226	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—SLC5A5—kidney cancer	8.28e-06	0.000225	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CYP1A1—kidney cancer	8.24e-06	0.000224	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GSTT1—kidney cancer	8.22e-06	0.000223	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ACHE—kidney cancer	8.22e-06	0.000223	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—SLC2A1—kidney cancer	8.06e-06	0.000219	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—SLC2A1—kidney cancer	7.99e-06	0.000217	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—POMC—kidney cancer	7.79e-06	0.000211	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—SCARB1—kidney cancer	7.78e-06	0.000211	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.76e-06	0.000211	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PTGS1—kidney cancer	7.7e-06	0.000209	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PSMD7—kidney cancer	7.55e-06	0.000205	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CRABP1—kidney cancer	7.48e-06	0.000203	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—BCHE—kidney cancer	7.16e-06	0.000194	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—SLC5A5—kidney cancer	7.07e-06	0.000192	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ITPR2—kidney cancer	6.96e-06	0.000189	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—SLC2A1—kidney cancer	6.83e-06	0.000185	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.76e-06	0.000184	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GSTP1—kidney cancer	6.73e-06	0.000183	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GSTP1—kidney cancer	6.67e-06	0.000181	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.63e-06	0.00018	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ABCB1—kidney cancer	6.37e-06	0.000173	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ACHE—kidney cancer	6.34e-06	0.000172	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTT1—kidney cancer	6.34e-06	0.000172	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ABCB1—kidney cancer	6.31e-06	0.000171	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—POMC—kidney cancer	6.28e-06	0.000171	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PTGS2—kidney cancer	6.21e-06	0.000169	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GSTM1—kidney cancer	6.18e-06	0.000168	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—POMC—kidney cancer	6.14e-06	0.000167	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GSTM1—kidney cancer	6.13e-06	0.000166	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SCARB1—kidney cancer	6e-06	0.000163	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PTGS1—kidney cancer	5.94e-06	0.000161	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CYP1A1—kidney cancer	5.86e-06	0.000159	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PSMD7—kidney cancer	5.83e-06	0.000158	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CYP1A1—kidney cancer	5.81e-06	0.000158	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.78e-06	0.000157	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GSTP1—kidney cancer	5.7e-06	0.000155	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—BCHE—kidney cancer	5.53e-06	0.00015	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SLC5A5—kidney cancer	5.46e-06	0.000148	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PTEN—kidney cancer	5.42e-06	0.000147	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ABCB1—kidney cancer	5.39e-06	0.000146	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SLC2A1—kidney cancer	5.27e-06	0.000143	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GSTM1—kidney cancer	5.24e-06	0.000142	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PTGS2—kidney cancer	5.01e-06	0.000136	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYP1A1—kidney cancer	4.96e-06	0.000135	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PTGS2—kidney cancer	4.9e-06	0.000133	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.77e-06	0.00013	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTP1—kidney cancer	4.4e-06	0.000119	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PTEN—kidney cancer	4.37e-06	0.000119	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—POMC—kidney cancer	4.37e-06	0.000119	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—POMC—kidney cancer	4.33e-06	0.000118	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PTEN—kidney cancer	4.27e-06	0.000116	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ABCB1—kidney cancer	4.16e-06	0.000113	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.08e-06	0.000111	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTM1—kidney cancer	4.04e-06	0.00011	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYP1A1—kidney cancer	3.83e-06	0.000104	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3CA—kidney cancer	3.82e-06	0.000104	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—POMC—kidney cancer	3.7e-06	0.0001	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PTGS2—kidney cancer	3.48e-06	9.46e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PTGS2—kidney cancer	3.45e-06	9.38e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3CA—kidney cancer	3.08e-06	8.37e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PTEN—kidney cancer	3.04e-06	8.25e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3CA—kidney cancer	3.01e-06	8.18e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PTEN—kidney cancer	3.01e-06	8.18e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PTGS2—kidney cancer	2.95e-06	8.01e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—POMC—kidney cancer	2.86e-06	7.75e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PTEN—kidney cancer	2.57e-06	6.99e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PTGS2—kidney cancer	2.28e-06	6.18e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3CA—kidney cancer	2.14e-06	5.82e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3CA—kidney cancer	2.12e-06	5.77e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PTEN—kidney cancer	1.99e-06	5.39e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.82e-06	4.93e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.4e-06	3.8e-05	CbGpPWpGaD
